Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
CNOOC
00883
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -670.71%-582.69K | -92.16%-204.93K | 48.24%-72.81K | 87.57%-337.13K | 98.20%-14.22K | 88.68%-75.6K | 84.25%-106.65K | 75.68%-140.67K | 24.95%-2.71M | 48.34%-788.92K |
| Net income from continuing operations | 44.15%-538.06K | 10.77%-1.19M | 27.26%-678.96K | -45.31%-13.7M | -359.79%-10.47M | 54.32%-963.35K | 52.43%-1.33M | 58.29%-933.46K | -63.80%-9.43M | -47.65%-2.28M |
| Operating gains losses | -98.31%2.63K | 4,668.83%633.73K | -186.99%-12.5K | -57.35%183.34K | --0 | --155.68K | --13.29K | --14.37K | --429.86K | ---- |
| Depreciation and amortization | -47.19%172K | -46.36%175.27K | -45.66%177.84K | 0.67%1.3M | -1.23%323.2K | -0.03%325.72K | 1.91%326.75K | 2.07%327.25K | 0.93%1.29M | 2.10%327.23K |
| Asset impairment expenditure | ---- | ---- | ---- | --9.88M | ---- | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | --0 | --0 | -98.73%1.03K | -78.54%418.89K | -99.21%1.75K | -99.52%4.28K | -33.77%331.97K | -75.52%80.88K | 74.44%1.95M | 30.79%221.48K |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | -203.02%-88.32K | 188.06%24.98K | -200.42%-85.26K | -127.87%-387.1K | -54,369.44%-301.22K | -129.65%-29.15K | -103.98%-28.36K | -104.91%-28.38K | 454.36%1.39M | ---553 |
| Change In working capital | -130.36%-130.92K | -57.49%248.51K | 28.56%512.54K | 18.91%1.97M | 7.83%550.56K | 266.56%431.21K | -1.57%584.62K | -7.38%398.67K | 493.35%1.65M | 180.28%510.59K |
| -Change in receivables | 101.14%98 | 59.52%-2.51K | 99.49%-41 | -85.29%13.12K | 144.57%35.96K | 32.51%-8.63K | -146.34%-6.19K | -108.94%-8.02K | 316.39%89.2K | 212.43%14.7K |
| -Change in prepaid assets | -366.05%-163.49K | -63.40%21K | -2,530.86%-38.6K | -86.47%134.31K | -69.85%13.91K | -74.30%61.45K | -83.61%57.36K | -99.56%1.59K | 230.14%992.84K | 124.90%46.14K |
| -Change in payables and accrued expense | -91.42%32.47K | -56.88%230.02K | 36.06%551.18K | 218.57%1.82M | 11.33%500.69K | 448.11%378.38K | 116.33%533.45K | 2,472.25%405.11K | 48.60%570.57K | 202.77%449.75K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -670.71%-582.69K | -92.16%-204.93K | 48.24%-72.81K | 87.57%-337.13K | 98.20%-14.22K | 88.68%-75.6K | 84.25%-106.65K | 75.68%-140.67K | 24.95%-2.71M | 48.34%-788.92K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 949.37K | 0 | 0 | 91.50%-380 | 0 | 0 | 81.09%-190 | 84.52%-190 | -103.58%-4.47K | -100.70%-870 |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | ---1.23K | --0 |
| Net intangibles purchas and sale | --0 | --0 | --0 | 88.29%-380 | --0 | --0 | 81.09%-190 | ---190 | -645.75%-3.24K | -100.00%-870 |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --949.37K | --0 | --0 | 91.50%-380 | --0 | --0 | 81.09%-190 | 84.52%-190 | -103.58%-4.47K | -100.70%-870 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 64.41%102.9K | 105.35%233.02K | -29.78%66.57K | -55.18%291.98K | -96.43%21.12K | 4.31%62.59K | 113.47K | 94.8K | 97.39%651.4K | 79.21%591.4K |
| Net issuance payments of debt | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -93.94%20K | ---- |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --587K | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --60K | --0 |
| Net other financing activities | 64.41%102.9K | -70.90%33.02K | -29.78%66.57K | 1,971.65%291.98K | --21.12K | --62.59K | --113.47K | --94.8K | ---15.6K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 64.41%102.9K | 105.35%233.02K | -29.78%66.57K | -55.18%291.98K | -96.43%21.12K | 4.31%62.59K | --113.47K | --94.8K | 97.39%651.4K | 79.21%591.4K |
| Net cash flow | ||||||||||
| Beginning cash position | 62.20%41.04K | -30.64%12.95K | -70.36%19.19K | -96.96%64.72K | -95.33%12.28K | -97.10%25.3K | -98.80%18.66K | -96.96%64.72K | -59.73%2.13M | -91.78%263.12K |
| Current changes in cash | 3,707.50%469.59K | 323.28%28.09K | 86.45%-6.24K | 97.80%-45.54K | 103.48%6.9K | 97.86%-13.02K | 100.98%6.64K | 92.05%-46.06K | 34.62%-2.07M | 81.50%-198.39K |
| End cash Position | 4,056.85%510.63K | 62.20%41.04K | -30.64%12.95K | -70.36%19.19K | -70.36%19.19K | -95.33%12.28K | -97.10%25.3K | -98.80%18.66K | -96.96%64.72K | -96.96%64.72K |
| Free cash from | -670.71%-582.69K | -91.82%-204.93K | 48.31%-72.81K | 87.58%-337.51K | 98.20%-14.22K | 88.71%-75.6K | 84.24%-106.84K | 75.70%-140.86K | 24.84%-2.72M | 48.30%-789.79K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.